Browse by Series:

FDA Acts Against Companies Selling Illegal Cancer Treatments and Clearance on Scalp Cooling System

Roy Herbst, MD
Published: Friday, Apr 28, 2017



Roy Herbst, MD, of Yale Cancer Center, reports on the FDA acting against companies illegally selling cancer treatments, an FDA clearance on a second scalp cooling system, promising phase III trials in breast cancer, and early findings with immunotherapy in liver cancer.
SELECTED
LANGUAGE
Slider Left
Slider Right


Roy Herbst, MD, of Yale Cancer Center, reports on the FDA acting against companies illegally selling cancer treatments, an FDA clearance on a second scalp cooling system, promising phase III trials in breast cancer, and early findings with immunotherapy in liver cancer.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients With Graft-Versus-Host DiseaseMar 28, 20192.0
2017 Year in Review™: Clinical Impact of Immunotherapies in the Treatment of CancerMar 30, 20191.75
Publication Bottom Border
Border Publication
x